Print version of this report
TGA Action ID RC-2025-RN-00450-1
Type of Product Medical Device
Product Name/Description AVVIGO + Multi-Modality Guidance System when used with OptiCross 18 Peripheral Imaging Catheter

Product Descriptions: AVVIGO + MOB SYSTEM EU + ROW, AVVIGO + MOB SYSTEM - REFURB EU + ROW, AVVIGO + MOB SYSTEM - ZERO COST EU + RO, AVVIGO + INT SYSTEM EU + ROW, AVVIGO + INT SYSTEM - REFURB EU + ROW

Material Numbers: H7492493320C0, H7492493320CR0, H7492493320CZ0, H7492493320I0, H7492493320IR0

GTIN/UDI: 00191506033309, 00191506033316, 00191506033323, 00191506033361
ARTG Number 391872
Action Type Product Correction
Action Level Hospital
Hazard Classification Class II
Reason for the Action Through a previous notification, RC-2024-RN-00786-1, Boston Scientific notified customers of a potential software anomaly that can occur when the AVVIGO+ Multi-Modality Guidance System is connected to an OptiCross 18 Imaging Catheter. When in Live or Record mode, the grid mark overlay on cross-sectional view would not display correctly.

Boston Scientific has developed a software update to correct this anomaly and will contact customers to schedule an update to their AVVIGO+ Multi-Modality Guidance System.
Instructions for Customers/Users Boston Scientific will contact customers to schedule the software update.

In the meantime, continue to follow the recommendations below, which were previously provided in the RC-2025-RN-00450-1 communication:
- Physicians should use the measurement tools available in Review mode only, to take vessel measurements (refer to detailed instructions included within the AVVIGO+ Multi-Modality Guidance System Instructions for Use, IFU).
- If measuring using grid mark overlay is preferred, it should only be performed in Review mode. Additionally, a physician can manually adjust the depth settings through the ‘Case Settings’ menu or elect to remove the grid marks from the display at time of use.

Following completion of the software update it will no longer be necessary to follow these recommendations.

This action has been closed out on 06/10/2026
Action Commencement Date 8/05/2025
Responsible Entity Boston Scientific Pty Ltd
Contact Information 02 8063 8340 - Boston Scientific representative